Vice President, CMC Drug & Device Development

The Vice President, CMC Drug & Device Development leads the Chemistry, Manufacturing, and Controls (CMC) strategy and execution for Kailera's pipeline of GLP-1-based therapies, advancing products from late-stage clinical development through regulatory filing and commercial launch. This leadership role oversees drug substance and product development, device and combination product engineering, and the scaling of a high-performing CMC organization. The position partners closely with cross-functional teams to ensure a robust, compliant, and scalable supply chain for the company's medicines.